2012
DOI: 10.1590/s0102-695x2012005000020
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Woodfordia fruticosa on dexamethasone induced insulin resistance in mice

Abstract: Diabetes is a group of syndrome characterized by hyperglycemia, altered metabolism of lipids, carbohydrates and proteins, resulting in an increased risk of complications from vascular disease. The fl owers of Woodfordia fruticosa (L.) Kurz, Lythraceae, have been used traditionally in the treatment of diabetes, dysentery, diarrhea, other bowel complaints, internal haemorrhages, in leucorrhoea and menorrhagia. Externally powdered fl ower is sprinkled over foul ulcers and wounds for diminishing their discharge an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 10 publications
0
6
0
Order By: Relevance
“…Many factors clarify hyperglycemia after dexamethasone administration, such as decreased insulin sensitivity, attenuated pancreatic α- and β-cell functions, and augmented hepatic gluconeogenesis [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…Many factors clarify hyperglycemia after dexamethasone administration, such as decreased insulin sensitivity, attenuated pancreatic α- and β-cell functions, and augmented hepatic gluconeogenesis [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…Hyperlipidemia caused in Dex-induced diabetes is due to excess mobilization of fat from the adipose tissue, increase VLDL secretions by the liver and stimulate VLDL formation by the intestine, decreasing hepatic lipoprotein lipase activity that inhibit the removal of plasma VLDL and leading to an increase plasma VLDL level [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, phytol as a cholesterol lowering agent, it can be administered clinically to patients with type II diabetes, obesity or other patients in risk of cardiovascular diseases due to elevated cholesterol or triglycerides (patent/WO2009113952A1). In the present study, obese rats declared a noticeable increase in the level of glucose, while a significant reduction in its level in VLPE treated obese rats relative to obese untreated one .Many factors clarify increased level of blood glucose in obesity, such as decreased insulin sensitivity, attenuated pancreatic lipase and cell function, as well as augmented hepatic gluconeogenesis [55,56]. Feeding of excessive cholesterol induces hypercholesterolemia and arteriosclerosis and further elicits the progress of obesity and dyslipidemia in both humans and rodents by changing the levels of plasma cholesterol and triglyceride [57].…”
Section: G2 G4 G5mentioning
confidence: 80%